Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study

• Bendix Carstensen,
• Stephen C Bain,
• Hanan Amadid,
• Alice Clark,
• Liselotte Hyveled,
• Stephanie Seremetis,
• Frederik Flindt Kreiner

Affiliations

Bendix Carstensen

Clinical Epidemiology, Steno Diabetes Center, Gentofte, Denmark

Stephen C Bain

Diabetes Unit, University of Wales Swansea, Swansea, UK

Hanan Amadid

Novo Nordisk AS, Søborg, Denmark

Alice Clark

Novo Nordisk AS, Søborg, Denmark

Liselotte Hyveled

Novo Nordisk AS, Søborg, Denmark

Stephanie Seremetis

Novo Nordisk Inc, Plainsboro, New Jersey, USA

Frederik Flindt Kreiner

Novo Nordisk AS, Søborg, Denmark